SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-16-000237
Filing Date
2016-11-14
Accepted
2016-11-14 17:34:05
Documents
2
Period of Report
2016-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K lgnd8knovember2016restatme.htm 8-K 117869
2 EXHIBIT 99.1 lgnd8kex991.htm EX-99.1 94035
  Complete submission text file 0000886163-16-000237.txt   213131
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 161996237
SIC: 2834 Pharmaceutical Preparations